Files in This Item:


Title: Adverse events following immunization in South-East Asia Region 2008-2010 : report on WHO support to the training programme
Authors: World Health Organization, Regional Office for South-East Asia
Issue Date: 2011
Publisher: WHO Regional Office for South-East Asia
Place of publication: New Delhi
Language: English
Abstract: Most of the new and under-utilized vaccines have never been used in countries of the SEA Region in large population groups e.g: seasonal flu vaccine and Hib vaccine as monovalent vaccine and/or delivered along with DTP and HepB as a single combination vaccine. Serious Adverse Events Following Immunization are very rare. Vaccines are given to healthy children below five years of age, which is a very vulnerable age group in developing countries. Other coincidental cause of death can be easily miss-interpreted as vaccine reactions without proper investigation and causality analysis procedures. It is therefore critical for national regulatory authority (NRA) and national immunization programme (NIP) managers to monitor AEFI and establish a vaccine safety surveillance system within their countries. Because of the high level of sensitivity involved in case of serious AEFI it is also very important that all national immunization programmes establish a national AEFI committee to conduct analysis and to scientifically determine the causality of the event with the vaccine. This national AEFI committee will also have the responsibility to advise the Ministry of Health and the national immunization programme on activities to improve the vaccine safety surveillance system.
Gov't Doc #: SEA-Vaccine-137
Appears in Collections:Meeting Reports

Items in WHO IRIS are protected by copyright, with all rights reserved, unless otherwise indicated.